JAZZ - Jazz presents encouraging Phase 2 data for breast cancer treatment
2023-12-08 15:14:26 ET
More on Jazz Pharmaceuticals
- Jazz Pharmaceuticals PLC (JAZZ) Q3 2023 Earnings Call Transcript
- Jazz Pharmaceuticals plc 2023 Q3 - Results - Earnings Call Presentation
- Jazz Pharma: Playing The High Notes With Xywav
- UBS lowers Jazz to neutral, cites potential competition from Avadel drug
- Jazz Pharma enters collaboration to develop neurological drugs
For further details see:
Jazz presents encouraging Phase 2 data for breast cancer treatment